ArticleCancer & metabolism2018

Beta-hydroxybutyrate (3-OHB) can influence the energetic phenotype of breast cancer cells, but does not impact their proliferation and the response to chemotherapy or radiation.

Catharina Bartmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.